In mid-December 2014, a new case management order (CMO) was filed in the New Jersey Mirena IUD multicounty litigation (MCL). The CMO detailed the defendant's request to file motions for…
Read More
Pretrial proceedings are going smoothly in the testosterone multidistrict litigation (MDL) that is being held in an Illinois federal court. The testosterone MDL is scheduled to meet three times this…
Read More
An article recently published by UK news organization the Daily Mail describes the country's increased efforts in requiring physicians to adequately warn patients of the risks of using certain kinds…
Read More
A UCLA study published in December 2014 examined the use of selective serotonin reuptake inhibitors, or SSRIs, during pregnancy. The researchers used lab mice to observe the effects of SSRI…
Read More
The lives of twelve families have been permanently impacted by Lexapro, an antidepressant drug. These 12 families took their cases to court by filing individual Lexapro birth defects lawsuits targeting…
Read More
Janssen Pharmaceuticals, the arm of Johnson & Johnson behind the anti-seizure drug Topamax, is the target of over 100 lawsuits in the Philadelphia Court of Common Pleas. The pharmaceutical company…
Read More
Sales are down for testosterone replacement therapy drugs, such as the two most popular testosterone gels, Androgel and Axiron. After a huge spike in 2013 in prescriptions and sales, 2014…
Read More

The news has been overrun of late by research connecting testosterone replacement therapy with poor cardiovascular health. Though testosterone gel’s effects on heart health continue to be a major concern,…
Read More
The promises of improved well being made in advertisements for testosterone gel have attracted large numbers of men. However, these promises fall short, and obscure a serious testosterone gel side…
Read More
The New England Journal of Medicine (NEJM) recently conducted a community poll on testosterone gel safety that concluded on December 2, 2014. The purpose of the poll was to get…
Read More